Sandoz Broncho-munal P caps. 3.5mg No. 30
Short review
Selected in the rating
16
Best rating
antiviral drugs
For adults - For children - For ARVI - For colds - Tablets / capsules
Buy Sandoz Broncho-Munal P caps. 3.5mg No. 30
Characteristics of Sandoz Broncho-munal P caps. 3.5mg No. 30
Yandex.Market data
| General characteristics | |
| Drug type | medicinal product |
| Organs and systems | respiratory system, immune system |
| Appointment | bronchitis, treatment of acute respiratory infections of the upper respiratory tract |
| Indications for use | Broncho-munal P is used in children aged 6 months to 12 years: - as part of the complex therapy of acute respiratory tract infections; - for the prevention of recurrent respiratory tract infections and exacerbations of chronic bronchitis. |
| Contraindications | Hypersensitivity to the components of the drug; - pregnancy; - the period of breastfeeding; - children under 6 months of age. |
| Structure | 1 capsule contains: active substances: standardized lyophilizate of bacterial lysates (OM-85) - 20.0 mg: lyophilized bacterial lysates - 3.50 mg: Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus viridans, Streptococcus pyogenes, Klebsiella Stylus pneumoniae, Klebsiapella o aureus, Moraxella catarrhalis; excipients: propyl gallate (anhydrous) - 0.042 mg; sodium glutamate (anhydrous) - 1.515 mg; mannitol - up to 20,000 mg, magnesium stearate - 3,000 mg; pregelatinized starch - 110,000 mg, mannitol - up to 200.00 mg; capsule shell: indigotine E132 - 0.009 mg, titanium dioxide E171 - 0.98 mg, gelatin - up to 50 mg. |
| Active substance | Bacterial lysates |
| Dosage | 3.5 mg |
| Method of administration and dosage | The drug is taken 1 capsule a day in the morning, on an empty stomach, 30 minutes before meals. For children under 3 years of age or if it is difficult for a child to swallow the capsule, it should be opened, the contents mixed with a small amount of liquid (tea, milk or juice). - To prevent recurrent respiratory tract infections and exacerbations of chronic bronchitis, the drug is used in three courses of 10 days, the interval between courses is 20 days. - As part of the complex therapy of acute respiratory tract infections, the drug is used until the symptoms disappear, but not less than 10 days. When carrying out antibiotic therapy, Broncho-Munal P should be taken in combination with antibiotics from the beginning of treatment. For the next 2 months, prophylactic use of the drug is possible: courses of 10 days, the interval between courses is 20 days. |
| Side effects | Broncho-munal P is usually well tolerated. Most adverse reactions are categorized as moderate to moderate to severe. The most common manifestation of side effects is gastrointestinal upset, skin reactions and respiratory disorders. According to the World Health Organization (WHO), adverse effects are classified according to their frequency of development as follows: - very common (≥ 1/10) ; - often (≥1 / 100, <1/10); - infrequently (≥1 / 1000, <1/100); - rarely (≥ 1/10000, <1/1000); - very rarely (<1 / 10000); - the frequency is unknown (the frequency of occurrence of the phenomena cannot be determined based on the available data). Disorders from the gastrointestinal tract are often: diarrhea, abdominal pain; frequency unknown: nausea, vomiting. Respiratory system disorders often: cough; infrequently: shortness of breath. Skin and subcutaneous tissue disorders often: rash; frequency unknown: urticaria, angioedema. Immune system disorders infrequently: hypersensitivity reactions (erythematous rash, generalized rash, erythema, edema, eyelid edema, facial edema, peripheral edema, swelling, facial swelling, pruritus, generalized itching). side of the nervous system, the frequency is unknown: headache. General disorders, the frequency is unknown: fever, fatigue. |
| pharmachologic effect | The drug Broncho-munal P has an immunostimulating effect, enhancing immunity against respiratory tract infections. After taking the capsule, the bacterial lysate accumulates in Peyer's patches of the gastrointestinal mucosa, in particular, located in the small intestine. Antigen-presenting cells in Peyer's patches are activated by bacterial lysate and subsequently stimulate other types of cells (B-lymphocytes) responsible for specific immunity. This leads to an increase in the number of circulating B-lymphocytes, which leads to an increase in the production of polyclonal antibodies, especially serum IgG and IgA, secreted by the mucous membrane of the respiratory tract and salivary glands. The drug also stimulates the majority of leukocytes, which is characterized by an increase in the number of cells of the myeloid and lymphoid series. as well as a selective increase in the expression of receptors on the surface. In patients receiving the drug Broncho-munal P, the body's protective properties against bacteria and viruses are enhanced. Clinically, Broncho-munal P reduces the frequency of acute respiratory tract infections, shortens their duration, reduces the likelihood of exacerbations of chronic bronchitis and also increases the body's resistance to infections of the respiratory system. This reduces the need to use other drugs, especially antibiotics. |
| Pharmacological group | immunostimulating agent |
| Release form | capsules |
| Method of application / administration | oral |
| Minimum age of use | from 6 months |
| Additionally | |
| Storage conditions | At temperatures from 15 to 25 ° C. The drug should be kept out of the reach of children. |
| Overdose | There are no reports of intoxication due to drug overdose. The nature of the drug Broncho-munal P and the results of a study of its toxicity in animals indicate that an overdose is unlikely. |
| Application during pregnancy and lactation | Animal studies have not shown any adverse effects on pregnancy. The safety and efficacy of using the drug during pregnancy and during breastfeeding has not been studied, therefore, the use of the drug Broncho-munal P during pregnancy and during breastfeeding is contraindicated. |
| Influence on the ability to drive vehicles and mechanisms | The drug does not affect the ability to concentrate and drive vehicles, mechanisms. |
| special instructions | To avoid overdose, children from 6 months to 12 years old should not use the drug Broncho-munal capsules 7 mg, intended for adults. Hypersensitivity reactions to the drug are possible. In case of persisting gastrointestinal disorders, skin reactions, respiratory disorders or other symptoms of drug intolerance, it is necessary to discontinue the drug and consult a doctor. |
| Interaction | There was no interaction of the drug with other drugs. The drug can be used concurrently with other medicines, including antibiotics. |
| Registration number | P N011633 / 01 |
| Date of state registration | 12.10.2015 |
| Marketing Authorization Holder | Sandoz |
| Manufacturer | Lek |
| Packer | Lek |
| Brand country | Slovenia |
| Manufacturer country | Slovenia |
| Drug name | Broncho-Munal |
Reviews about Sandoz Broncho-Munal P caps. 3.5mg No. 30
Yandex.Market data
Advantages:
Helped in treatment. Unusually, the reception is 10 days. Now I use it as a prophylaxis for an older child. Let's see what happens.
Disadvantages:
The price is of course expensive.I order via the Internet and applications and then I consider 502p expensive at a time and then 2 more times. At retail, buy from 550 to 650 rubles.
Comment:
If you have contacted this drug and it "suits you" - buy in bulk. There is a box of 30 capsules for a full course. Order online. My example: I bought on 11/01/19 = 1250r for 30 capsules 3.5mg. Search! Good luck and don't get sick! )
November 10, 2019, St. Petersburg
